AI pre-screen
Possible
64/100
Meets the core inclusion criteria; a couple of items to confirm at the screening visit.
Screening detail
Meets criteria
Age within the protocol range
Reported diagnosis of Major Depressive Disorder aligns with inclusion
No exclusionary condition reported on the screener
To confirm
Confirm current episode duration is in range
Verify prior antidepressant response history
Step 2 · Message William
Write them from the thread on this page. We do not email applicants a calendar or ask them to pick a time.
AI-assisted decision support. A qualified team member must review and decide.
Messages
Applied Aug 16 · via ClinicalTrials.gov
Your screening visit is booked for 2026-08-19 13:00 at Northwind Clinical Research. We'll remind you beforehand.
Hi William, thanks for applying - you look like a strong fit. Any questions before we book your screening visit?
Will taking part affect the care I get from my own doctor?
Reminder: your screening visit is on 2026-09-19 09:00 at Northwind Clinical Research. Showing up is the key step - reply here if anything's in the way.
Contact & details
Applied to
Azetukalner Open-Label Extension in Major Depressive Disorder (X-NOVA-OLE)
NCT06922110
Stage advances from what you do. Accepting marks them likely eligible; booking a visit moves them to screening.
Patient portal
Give William P. a private page to follow their own status, see what's outstanding, and message you back , no account signup. The link and a one-time password are sent straight to their message thread.
Notes team-only
Type @ to pull a teammate into this thread instead of CC-ing them on an email.
No notes yet. Jot context only your team sees.
Tasks
No to-dos yet.
Screening answers
Can travel to the study site
Yes
Currently in another trial
No
Pregnant / planning pregnancy
No
Can give own consent
Yes
Documents
Timeline
application received
2026-07-14 06:34 · you
ready for study-team review
2026-07-14 06:34 · you
accepted - likely eligible
2026-08-15 06:34 · you
invited to screening visit
2026-08-16 06:34 · site